The α7 nicotinic acetylcholine receptor (α7 nAChR) is a key modulator of neuronal and immunological signaling, and photopharmacology offers a route to control nicotinic transmission with high spatiotemporal precision. Here we report CPZ-2, a photoswitchable ligand inspired by a patented α7-active scaffold. CPZ-2 shows slow thermal relaxation, high photostability, and reversible photoswitching under one-photon irradiation, together with two-photon-induced photoisomerization monitored directly by HPLC-MS. Radioligand-binding competition performed on the trans-enriched state showed measurable displacement at α7 nAChRs and α1-containing receptors at 10 µM, with lower effects at α3β4 and α4β2 subtypes. Moreover, in wild-type zebrafish larvae, CPZ-2 modulated nicotine-evoked locomotion in a light-dependent manner after bath application. Finally, docking simulations in the α7 orthosteric site support a binding mode compatible with receptor engagement and suggest photostate-dependent differences in the orientation of the distal aromatic group relative to the C-loop region. Together, these data identify CPZ-2 as an uncharged, diffusible photoswitchable nicotinic ligand that combines robust one- and two-photon photochemistry with light-dependent modulation of nicotinic signaling in a wild-type vertebrate model.

Photocontrol of zebrafish behavior with a photoswitchable ligand of nicotinic acetylcholine receptors / C. Papotto, N.F.P.. - In: BIOMÉDECINE & PHARMACOTHÉRAPIE. - ISSN 0753-3322. - 201:(2026 Aug), pp. 119727.1-119727.14. [10.1016/j.biopha.2026.119727]

Photocontrol of zebrafish behavior with a photoswitchable ligand of nicotinic acetylcholine receptors

C. Papotto
Primo
;
M. De Amici;C. Dallanoce;C. Matera
Ultimo
2026

Abstract

The α7 nicotinic acetylcholine receptor (α7 nAChR) is a key modulator of neuronal and immunological signaling, and photopharmacology offers a route to control nicotinic transmission with high spatiotemporal precision. Here we report CPZ-2, a photoswitchable ligand inspired by a patented α7-active scaffold. CPZ-2 shows slow thermal relaxation, high photostability, and reversible photoswitching under one-photon irradiation, together with two-photon-induced photoisomerization monitored directly by HPLC-MS. Radioligand-binding competition performed on the trans-enriched state showed measurable displacement at α7 nAChRs and α1-containing receptors at 10 µM, with lower effects at α3β4 and α4β2 subtypes. Moreover, in wild-type zebrafish larvae, CPZ-2 modulated nicotine-evoked locomotion in a light-dependent manner after bath application. Finally, docking simulations in the α7 orthosteric site support a binding mode compatible with receptor engagement and suggest photostate-dependent differences in the orientation of the distal aromatic group relative to the C-loop region. Together, these data identify CPZ-2 as an uncharged, diffusible photoswitchable nicotinic ligand that combines robust one- and two-photon photochemistry with light-dependent modulation of nicotinic signaling in a wild-type vertebrate model.
English
Nicotinic Acetylcholine Receptor; Photopharmacology; Photoswitchable Ligand; Two-Photon Activation; Two-Photon Pharmacology; Zebrafish Behavioral Assay
Settore CHEM-07/A - Chimica farmaceutica
Settore BIOS-11/A - Farmacologia
Articolo
Esperti anonimi
Ricerca di base
Pubblicazione scientifica
Goal 3: Good health and well-being
   Human Brain Project Specific Grant Agreement 3 (HBP SGA3)
   HBP SGA3
   EUROPEAN COMMISSION
   H2020
   945539

   LUMINESCENT IMPLANTS AS PORTS FOR LIGHT-BASED THERAPIES
   PHOTOTHERAPORT
   European Commission
   Horizon Europe Framework Programme - HORIZON EIC Grants
   101130883

   DEEP BRAIN PHOTONIC TOOLS FOR CELL-TYPE SPECIFIC TARGETING OF NEURAL DISEASES
   DEEPER
   European Commission
   Horizon 2020 Framework Programme - Research and Innovation action
   101016787
ago-2026
Elsevier
201
119727
1
14
14
Pubblicato
Periodico con rilevanza internazionale
scopus
Aderisco
info:eu-repo/semantics/article
Photocontrol of zebrafish behavior with a photoswitchable ligand of nicotinic acetylcholine receptors / C. Papotto, N.F.P.. - In: BIOMÉDECINE & PHARMACOTHÉRAPIE. - ISSN 0753-3322. - 201:(2026 Aug), pp. 119727.1-119727.14. [10.1016/j.biopha.2026.119727]
open
Prodotti della ricerca::01 - Articolo su periodico
11
262
Article (author)
Periodico con Impact Factor
C. Papotto, N.F. Pérez-Pérez, A.M.J. Gomila, R. Sortino, M. Cases, H. Lee, F. Calzaferri, M. De Amici, C. Dallanoce, P. Gorostiza, C. Matera...espandi
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0753332226007638-main_compressed.pdf

accesso aperto

Descrizione: main text
Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 7.08 MB
Formato Adobe PDF
7.08 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1261895
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact